Stay updated on Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6. This reflects a minor update to the page's metadata rather than changes to the visible content.
    Difference
    0.1%
    Check dated 2026-08-29T19:35:20.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.4 to v3.6.5, indicating a minor platform update. There is no indication that study content, eligibility criteria, or results text has changed.
    Difference
    0.1%
    Check dated 2026-08-08T19:02:34.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, representing a minor update to the page metadata. This change does not affect the study details, endpoints, or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-07-25T10:51:28.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now shows a newer revision line (v3.6.3) for the study documents, replacing the previous v3.6.2. This reflects an updated protocol/SAP version in the documents section.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:48.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page shows an updated revision tag, replacing v3.6.0 with v3.6.2, reflecting a newer deployment of the page system. This change does not modify study content or related data.
    Difference
    0.1%
    Check dated 2026-06-27T00:12:26.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    New user-help sections were added, and the page revision and verification status indicators were updated to reflect current study details.
    Difference
    2%
    Check dated 2026-06-12T16:48:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Epacadostat in Thymic Carcinoma Clinical Trial page.